WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Cerrar esta carpetaParasitic infections
Ver el documentoPediculosis
Ver el documentoScabies
Ver el documentoCutaneous larva migrans (creeping eruption)
Ver el documentoGnathostomiasis
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Abrir esta carpeta y ver su contenidoScabicides and pediculicides
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Cutaneous larva migrans (creeping eruption)

Cutaneous larva migrans results when the larvae of the hookworms Ancylostoma braziliense and A. caninum, which are excreted by infected dogs and cats, penetrate intact skin. Other nematode species have also been implicated. The condition is particularly prevalent in Central America, some countries of South America, the Caribbean and the southeastern United States, and throughout tropical Africa. It is characterized by pruritic, winding, thread-like inflammatory lesions, most commonly on the feet.

In most cases, the larvae remain localized, causing only a transient focal dermatitis of varying intensity. They do not mature into adult worms in humans but, occasionally, they migrate to the lungs to cause eosinophilia, cough and pulmonary infiltrates (Loeffler syndrome).

Control

Prevention is directed to interrupting transmission. Regular deworming of dogs and cats reduces contamination of soil and protective footwear reduces the likelihood of contact.

Treatment

Albendazole administered orally in a single dose of 400 mg cures almost all cases.1 Tiabendazole may also be of value when administered topically twice or three times daily for 7-10 days. Calamine lotion provides symptomatic relief.

1 For further information, see WHO model prescribing information: drugs used in parasitic diseases, 2nd ed. Geneva, World Health Organization, 1995.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 19 enero 2012